Nuvectis Pharma
NVCT
NVCT
31 hedge funds and large institutions have $6.6M invested in Nuvectis Pharma in 2024 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 9 increasing their positions, 12 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
77% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 13
Holders
31
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$364K | |
| 2 | +$329K | |
| 3 | +$174K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$174K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$95.1K |
Top Sellers
| 1 | -$390K | |
| 2 | -$386K | |
| 3 | -$335K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$227K |
| 5 |
BlackRock
New York
|
-$223K |